High Tide Closes Acquisition of a Majority Stake in Remexian Pharma

It has an option to acquire the remaining 49%.

I Stock 833712532
Yarphoto/iStock

High Tide said it has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of €26.4 million and it will have a five-year option to acquire the remaining 49% of Remexian at any time after 24 months.

"Today marks a transformational moment in High Tide's journey as we officially plant our flag in Europe. With the closing of this majority acquisition of Remexian, High Tide is no longer just a Canadian success story—we are now a global cannabis company with real scale in Europe's largest federally regulated market," said Raj Grover, Founder and Chief Executive Officer of High Tide. "This transaction not only diversifies our revenue base beyond Canada but also creates a clear runway for expansion across Europe's regulated cannabis markets. With our proven track record of disciplined growth and free cash flow generation, we believe this acquisition positions High Tide for long-term global leadership."

High Tide's operations include Canna Cabana, a cannabis retail chain in Canada with 207 current locations spanning British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, along with Fastendr, a fully automated technology that employs retail kiosks to facilitate a better buying experience through browsing, ordering and pickup.

More in News